Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
MRK News
New insider activity at Merck & Company ( (MRK) ) has taken place on February 21, 2025. Discover the Best Stocks and Maximize Your Portfolio: See what stocks...
Merck (MRK) and a woman suing the company have agreed to pause a trial over alleged injuries linked to its human papillomavirus vaccine, a case connected to U.S...
Merck (NYSE:MRK) announced Tuesday that the European Commission approved its anti-cancer agent Welireg (belzutifan) as a treatment for two tumor conditions link...
Analyst ratings
65%
of 26 ratingsMore MRK News
On Tuesday, the European Commission (EC) conditionally approved Merck & Co Inc’s MRK Welireg (belzutifan), an oral hypoxia-inducible factor-2 alpha (HIF-2α) inh...
Merck (MRK) announced that the European Commission has conditionally approved WELIREG, Merck’s oral hypoxia-inducible factor-2 alpha inhibitor, as monotherapy f...
Deutsche Bank analyst James Shin downgraded Merck (MRK) to Hold from Buy with a price target of $105, down from $128. The firm believes the “real culprit” for M...
Deutsche Bank analyst James Shin downgraded Merck (MRK) to Hold from Buy with a $105 price target Published first on TheFly – the ultimate source for real-time...
A weekly summary of insider trading highlighting a few notable buying and selling by investors, directors and executives. The trades have taken place between Fe...
